Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuartix Tech Regulatory News (QTX)

Share Price Information for Quartix Tech (QTX)

Share Price is delayed by 15 minutes
Get Live Data
262.50    -2.50 (-0.94%)
Bid:
260.00
Ask:
265.00
Spread: 5.00 (1.923%)
Market Cap: £127.20m
QTX Live PriceLast checked at - London Stock Exchange

Intraday Quartix Tech Share Chart

Trading Statement

22 Apr 2026 07:00

RNS Number : 3692B
Quartix Technologies PLC
22 April 2026
 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 as retained as part of UK law by virtue of the European Union (Withdrawal) Act 2018 as amended.

 

Quartix Technologies plc

 

("Quartix", "the Group" or "the Company")

 

Trading Statement

 

Quartix Technologies plc, a leading supplier of subscription-based vehicle tracking systems, software and services, is pleased to provide the following trading statement ahead of the Annual General Meeting later today, covering the first three months of 2026 ("Q1"). 

Financial Performance

The Group has made a good start to the year, with continued growth in ARR, net revenue retention, vehicle subscriptions and customer base in each territory we operate in in Q1. By comparison to a very strong first quarter last year, new subscriptions and the rate of customer acquisition were lower year on year but prospects remain encouraging for the rest of the year and the Company maintains its focus on the improvement of sales and marketing efficiency.

Revenue and profit are in line with achievement of market expectations for the year1.

Free cashflow for Q1 was very strong and is expected to have been £2.7m, leaving the Company with a closing cash balance of £8.2m. £0.55m of this improvement resulted from a refund of corporation tax relating to the re-submission of FY 23 tax return and £0.35m from a delay Q1 tax payment that cleared the bank in April.

In the 2025 Annual Report, the Company indicated that a payment of £1.1m was expected to be made to HMRC by 31 March 2026 in respect of UK corporation tax. As no payment details or confirmation of the amount due have yet been received from HMRC, the Company now expects this cash outflow to occur in Q2 2026.

Annualised Recurring Revenue ("ARR")

ARR is the key forward-looking measure of growth for the Company and an important indicator of shareholder value. ARR reported by the Company relates solely to committed software subscription revenues and does not include other service revenues which may recur.

The Company's ARR increased by £1.6m in the Period to £38.6m on a constantcurrency basis. On a trailingtwelvemonth basis, ARR has grown by £4.1m, or 12%. Of the £1.6m growth in the Period, £1.1m was derived from new business. Following a particularly strong Q1 2025 performance, the ARR growth in Q1 is around 20% lower than the ARR growth achieved in the same period of the prior year. Net revenue retention increased from 95.7% to 98.1% in the twelve months ending 31 March 2026, and further improvement in this measure remains a management focus.

Measures of ARR and ARR growth are calculated on a constant-currency basis4.

Customer acquisition

New customer acquisition in Q1 decreased by 8% to 2,021 and new subscriptions decreased by 13% to 19,301 compared with the same threemonth period in 2025. On a TTM basis, however, the customer base increased by 8% to 33,443 and the total subscription base increased by 9% to 339,491, reflecting continued expansion of the installed base despite the reduced growth in new customers and units in Q1 as compared to Q1 2025.

The key metrics for the Group are shown below:

Country

ARR (£m)

% Growth (TTM)

Sub Base (units)

% Growth (TTM)

Customer Base

% Growth (TTM)

New Subs (units)

% Growth (Q1)

New Customers Acquired

% Growth (Q1)

UK/EI

20.28

+8%

168,204

+4%

11,993

+1%

6,422

-28%

428

-13%

France

10.48

+14%

94,762

+12%

10,012

+6%

6,431

-10%

647

-5%

USA

3.38

+5%

29,642

+1%

4,023

+3%

1,558

-25%

236

-12%

Italy

2.12

+39%

22,061

+40%

3,457

+38%

2,583

+33%

355

+4%

Spain

1.38

+32%

15,948

+30%

2,675

+20%

1,470

+13%

240

-12%

Germany

0.93

+45%

8,506

+20%

1,224

+19%

811

6%

113

-23%

Other

0.04

368

59

26

2

Total

38.61

+12%

339,491

+9%

33,443

+8%

19,301

-13%

2,021

-8%

 

4G Upgrade Programmes

Good progress has been made on the 4G upgrade programme in France, which remains on schedule to conclude this year. Replacement of 2G tracking systems in the UK is continuing on the schedule noted in the Company's 2025 Annual Report.

Outlook

Andy Walters, Executive Chairman of Quartix, commented:

"The Company has made a solid start to 2026, with continued growth in annualised recurring revenue, strong net revenue retention and further expansion of our international customer base. ARR increased to £38.6m on a constantcurrency basis at 31 March 2026, with £1.1m of this growth coming from new business, and net revenue retention improving to 98.1% over the twelve months to that date. The Company continues to focus on the effectiveness of its sales and marketing initiatives and is confident of achieving market expectations for the year.

 

 Notes:

1 The Company believes that market expectations for 2026 were, prior to this announcement, revenue £40.3m, Adjusted EBIT £10.1m and free cashflow of £4.7m.

2 Comparisons made on the basis of constant-currency measurements are based on closing exchange rates applicable at 31/03/2026 of $1.332 and €1.148 to pounds sterling.

For further Information please contact:

Quartix (www.quartix.com)

Andrew Walters, Executive Chairman

Sally Morton, Company Secretary

 

01686 806 663

Cavendish Capital Markets Limited (Nominated Adviser and Broker)

Matt Goode / Seamus Fricker / Trisyia Jamaludin (Corporate Finance)

Sunila de Silva (Equity Capital Markets)

020 7200 0500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFZGZDKMKGVZM
Date   Source Headline
2nd Jun 202612:17 pmRNSDirector/PDMR Shareholding
22nd Apr 20265:20 pmRNSResult of AGM
22nd Apr 20267:00 amRNSTrading Statement
8th Apr 202612:16 pmRNSDirector/PDMR Dealing, TVR & Investor Webinar
25th Mar 20267:00 amRNSFinal Results
20th Mar 20264:18 pmRNSNotice of Results
23rd Feb 20267:00 amRNSNotice of Results
11th Feb 20267:00 amRNSFRC Review, Accounting Policy & Notice of Results
8th Jan 20267:00 amRNSTrading Update
15th Dec 20255:47 pmRNSDirector/PDMR Shareholding
18th Nov 20252:15 pmRNSHolding(s) in Company
27th Oct 202512:49 pmRNSDirector/PDMR Shareholding
6th Oct 20255:37 pmRNSGrant of Options
6th Oct 20257:01 amRNS-RMelloMonday Investor Webinar
6th Oct 20257:00 amRNSTrading Statement
24th Jul 20257:00 amRNSInterim Results
3rd Jul 20257:00 amRNSTrading Statement
7th Apr 20257:00 amRNSTrading Statement
31st Mar 20253:52 pmRNSDirector/PDMR Shareholding
31st Mar 20251:30 pmRNSResult of AGM
31st Mar 20257:00 amRNSAGM Trading Statement
3rd Mar 20257:00 amRNSFinal Results
13th Feb 202510:00 amRNSInvestor Presentation via Investor Meet Company
13th Jan 20257:00 amRNSTrading Statement
15th Oct 20247:00 amRNSTrading Statement
28th Aug 202410:58 amRNSDirector/PDMR Shareholding
29th Jul 20247:00 amRNSInterim Results
8th Jul 20247:00 amRNSTrading Statement
15th May 20246:24 pmRNSGranting of Options
27th Mar 20244:00 pmRNSResult of AGM
27th Mar 20247:00 amRNSAGM Trading Statement and Directorate Change
4th Mar 20247:00 amRNSFinal Results
19th Feb 20247:00 amRNSDirectorate Changes
24th Jan 20245:45 pmRNSHolding(s) in Company
23rd Jan 20245:00 pmRNSDirector/PDMR Shareholding - Replacement
23rd Jan 20241:09 pmRNSDirector/PDMR Shareholding
17th Jan 20243:51 pmRNSHolding(s) in Company
17th Jan 20241:45 pmRNSHolding(s) in Company
9th Jan 20247:00 amRNSTrading Statement
18th Dec 202311:45 amRNSHolding(s) in Company
11th Dec 20237:00 amRNSKonetik update
28th Nov 20237:00 amRNSDirectorate Changes
10th Nov 20234:01 pmRNSDirector/PDMR Shareholding
11th Oct 20237:00 amRNSBoard Changes - Replacement
10th Oct 20235:00 pmRNSBoard Changes
6th Oct 20237:00 amRNSTrading Update
26th Sep 20237:00 amRNSDirectorate Change
21st Sep 202311:00 amRNSDirector/PDMR Shareholding
15th Sep 20237:00 amRNSAcquisition of Konetik GmBH
3rd Aug 20233:50 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.